Behavioral Intervention for Insomnia in Older Adults
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01154023 |
Recruitment Status :
Completed
First Posted : June 30, 2010
Last Update Posted : June 30, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Sleep Initiation and Maintenance Disorders | Behavioral: stimulus control therapy, sleep restriction therapy, multi-component treatment (stimulus control therapy, sleep restriction therapy) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 179 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Behavioral Intervention for Insomnia in Older Adults |
Study Start Date : | September 2000 |
Actual Primary Completion Date : | August 2004 |
Actual Study Completion Date : | August 2004 |
Arm | Intervention/treatment |
---|---|
Experimental: stimulus control therapy
Focuses on strengthening the bed and bedroom as cues for sleepiness and sleep, weaken them as cues for arousal, and developing a consistent sleep-wake pattern
|
Behavioral: stimulus control therapy, sleep restriction therapy, multi-component treatment (stimulus control therapy, sleep restriction therapy)
Treatment was given weekly for 6 weeks. Sessions 1 - 4 were in a group format. Session 5 & 6 were delivered individually by phone. |
Experimental: sleep restriction therapy
Sleep restriction therapy consolidates sleep by restricting the amount of time spent in bed and limiting sleep to a specific time period .
|
Behavioral: stimulus control therapy, sleep restriction therapy, multi-component treatment (stimulus control therapy, sleep restriction therapy)
Treatment was given weekly for 6 weeks. Sessions 1 - 4 were in a group format. Session 5 & 6 were delivered individually by phone. |
Experimental: multi-component intervention
Combines stimulus control and sleep restriction: strengthen the bed and bedroom as cues for sleepiness and sleep, weaken them as cues for arousal, develop a consistent sleep-wake pattern, consolidate sleep by restricting the amount of time spent in bed and limit sleep to a specific time period
|
Behavioral: stimulus control therapy, sleep restriction therapy, multi-component treatment (stimulus control therapy, sleep restriction therapy)
Treatment was given weekly for 6 weeks. Sessions 1 - 4 were in a group format. Session 5 & 6 were delivered individually by phone. |
- subjective sleep [ Time Frame: 1 year ]daily sleep diaries were used for 2 weeks at each of the four measurement points, pre-treatment, post-treatment, 3 months and 1 year - called daily to voice mail service to avoid retrospective estimates of sleep
- insomnia severity [ Time Frame: 1 year ]Insomnia Severity Index was used at the four measurement points (pre-treatment, post-treatment, 3 months, and 1 year) and also included the significant other version of the instrument

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 55 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 55 years or older
- Sleep onset or maintenance insomnia of 45 minutes or more per night for at least 3 nights per week as ascertained through 14 days of sleep diaries
- Insomnia duration of at least 6 months
- Impaired daytime functioning as a consequence of insomnia
Exclusion Criteria:
- Psychopathology evidenced by the Brief Symptom Inventory Global Severity Index T score >60
- Cognitive impairment as ascertained by the Mini-Mental State Exam score < 27
- Current psychotherapy or medical treatment for major depression or other psychopathology
- Current and regular use of over-the-counter medication or prescription medication for sleep (verified through urinalysis), or any medication affecting sleep
- Major physical or mental illness directly related to the onset and course of insomnia
- Substance abuse problem ascertained per interview
- Suspicion of sleep apnea as determined by an Epworth Sleepiness Scale score of 11 or greater, a respiratory disturbance index of > 15 as established through in-home overnight use of the EdenTec Model 3711 Digital Recorder, and interview with a significant other, if available
- Restless leg syndrome, periodic limb movement disorder, or circadian rhythm sleep disorders as determined through the participant interview and an interview with a significant other, if available.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01154023
Principal Investigator: | Dana R Epstein, PhD, RN | Carl T. Hayden VA |
Responsible Party: | Dana R. Epstein, Carl T. Hayden Veterans Affairs Medical Center |
ClinicalTrials.gov Identifier: | NCT01154023 |
Other Study ID Numbers: |
R29NR004951 ( U.S. NIH Grant/Contract ) |
First Posted: | June 30, 2010 Key Record Dates |
Last Update Posted: | June 30, 2010 |
Last Verified: | June 2010 |
Sleep Initiation and Maintenance Disorders Behavior Therapy |
Sleep Initiation and Maintenance Disorders Sleep Disorders, Intrinsic Dyssomnias |
Sleep Wake Disorders Nervous System Diseases Mental Disorders |